Opening PharmaNL SDI subsidy call on March 18, 2025
March 18, 2025

ZonMw, the subsidy administrator of PharmaNL, opens a subsidy call within the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025. The objective of this subsidy call is to address the prioritized themes from PharmaNL’s investment agenda. View this investment agenda, published on January 30, 2025, here. Read the full news article about the […]

vooraankondiging
Pre-announcement PharmaNL Shared Development Infrastructure 2025
February 11, 2025

Great news! ZonMw, the managing organization of the PharmaNL subsidy program, is planning to launch a subsidy call for the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025! This subsidy supports the construction and upgrading of advanced infrastructure for pharmaceutical startups, scale-ups, and academic research groups. It’s a unique opportunity to collaborate and […]

investeringsagenda shared
PharmaNL publishes Investment Agenda for Shared Development Infrastructure
January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical […]

G2Solutions: Funding for Innovation in Single-Cell Genomics
September 17, 2024

The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding from PharmaNL under the PharmaNL Shared Development Infrastructure program for their five-year project. G2Solutions focuses on developing infrastructure for new drug development. “This project demonstrates that we can make unique technologies, such as single-cell sequencing […]

Nanoworx
Second Project Funding Round of PharmaNL Shared Development Infrastructure Launches
September 12, 2024

The project “Nanoworx,” led by Prof. Dr. Willem Mulder, will soon commence under the PharmaNL Shared Development Infrastructure program. Projects in this program aim to establish infrastructure provisions for groundbreaking pharmaceutical products and drug development technologies.

First Project Funding Round of PharmaNL Shared Development Infrastructure Launches
August 15, 2024

In the coming months, the first project ‘G2 Solutions’ will start under the leadership of Prof. Dr. Ir. Floris Foijer within the PharmaNL Shared Development Infrastructure program line. Projects within this program focus on establishing infrastructure provisions for groundbreaking pharmaceutical products and technologies for drug development. Objective of the Funding Round The PharmaNL Shared Development […]